Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
Year: 2020
Type: review
Source: Medicinal Research Reviews
DOI: 10.1002/med.21722
Authors: Svetlana I. Gavrilova, Anton Alvarez
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3081470197